nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0634	0.0652	CbGbCtD
Paramethadione—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0625	0.0643	CbGbCtD
Paramethadione—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0625	0.0643	CbGbCtD
Paramethadione—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0513	0.0528	CbGbCtD
Paramethadione—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0482	0.0496	CbGbCtD
Paramethadione—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0482	0.0496	CbGbCtD
Paramethadione—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0474	0.0487	CbGbCtD
Paramethadione—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0474	0.0487	CbGbCtD
Paramethadione—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0454	0.0467	CbGbCtD
Paramethadione—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0436	0.0449	CbGbCtD
Paramethadione—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0436	0.0449	CbGbCtD
Paramethadione—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0376	0.0387	CbGbCtD
Paramethadione—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0365	0.0376	CbGbCtD
Paramethadione—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.033	0.034	CbGbCtD
Paramethadione—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.033	0.034	CbGbCtD
Paramethadione—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0317	0.0326	CbGbCtD
Paramethadione—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0298	0.0307	CbGbCtD
Paramethadione—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.028	0.0288	CbGbCtD
Paramethadione—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.028	0.0288	CbGbCtD
Paramethadione—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0253	0.0261	CbGbCtD
Paramethadione—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0253	0.0261	CbGbCtD
Paramethadione—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0219	0.0225	CbGbCtD
Paramethadione—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0212	0.0219	CbGbCtD
Paramethadione—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0192	0.0198	CbGbCtD
Paramethadione—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0192	0.0198	CbGbCtD
Paramethadione—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0184	0.019	CbGbCtD
Paramethadione—CACNA1G—digestive system—acquired immunodeficiency syndrome	0.0024	0.0847	CbGeAlD
Paramethadione—CACNA1I—brain—acquired immunodeficiency syndrome	0.00207	0.073	CbGeAlD
Paramethadione—CACNA1I—lymph node—acquired immunodeficiency syndrome	0.002	0.0706	CbGeAlD
Paramethadione—CACNA1G—nervous system—acquired immunodeficiency syndrome	0.00186	0.0655	CbGeAlD
Paramethadione—CACNA1G—central nervous system—acquired immunodeficiency syndrome	0.00179	0.063	CbGeAlD
Paramethadione—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.0017	0.0598	CbGeAlD
Paramethadione—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00151	0.0531	CbGeAlD
Paramethadione—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0504	CbGeAlD
Paramethadione—CACNA1G—brain—acquired immunodeficiency syndrome	0.00142	0.0501	CbGeAlD
Paramethadione—CACNA1H—nervous system—acquired immunodeficiency syndrome	0.00122	0.0428	CbGeAlD
Paramethadione—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00115	0.0405	CbGeAlD
Paramethadione—CACNA1H—brain—acquired immunodeficiency syndrome	0.00093	0.0327	CbGeAlD
Paramethadione—CACNA1H—lymph node—acquired immunodeficiency syndrome	0.000899	0.0316	CbGeAlD
Paramethadione—CYP2C8—blood—acquired immunodeficiency syndrome	0.000623	0.0219	CbGeAlD
Paramethadione—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00058	0.0204	CbGeAlD
Paramethadione—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000577	0.0203	CbGeAlD
Paramethadione—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000557	0.0196	CbGeAlD
Paramethadione—CYP2C9—blood—acquired immunodeficiency syndrome	0.000553	0.0195	CbGeAlD
Paramethadione—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.00055	0.0194	CbGeAlD
Paramethadione—CYP2E1—blood—acquired immunodeficiency syndrome	0.000524	0.0185	CbGeAlD
Paramethadione—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000505	0.0178	CbGeAlD
Paramethadione—CYP2E1—lung—acquired immunodeficiency syndrome	0.000459	0.0162	CbGeAlD
Paramethadione—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000443	0.0156	CbGeAlD
Paramethadione—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000425	0.015	CbGeAlD
Paramethadione—CYP3A4—blood—acquired immunodeficiency syndrome	0.000422	0.0148	CbGeAlD
Paramethadione—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.00041	0.0144	CbGeAlD
Paramethadione—CYP2C8—brain—acquired immunodeficiency syndrome	0.000386	0.0136	CbGeAlD
Paramethadione—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000342	0.0121	CbGeAlD
Paramethadione—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00033	0.0116	CbGeAlD
Paramethadione—CYP2E1—brain—acquired immunodeficiency syndrome	0.000325	0.0114	CbGeAlD
